Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
2026 · third_quarter · Q3
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Filing targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Source: Senate LDA
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Promoting Resilient Supply Chains Act of 2025
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
S.257, the Promoting Resilient Supply Chains Act of 2025.
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025 Medical Supply Chain Resiliency Act (S. 998/HR 2213) Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act. Health cybersecurity legislation. Implementation of the Drug Supply Chain Security Act (DSCSA).
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213) Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act. Health cybersecurity legislation.
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.
Promoting Resilient Supply Chains Act of 2025
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
S.257, the Promoting Resilient Supply Chains Act of 2025.
Bipartisan Health Care Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.
Bipartisan Health Care Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025 Medical Supply Chain Resiliency Act (S. 998/HR 2213) Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act. Health cybersecurity legislation. Implementation of the Drug Supply Chain Security Act (DSCSA).
Bipartisan Health Care Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213) Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act. Health cybersecurity legislation.
Bipartisan Health Care Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025 Medical Supply Chain Resiliency Act (S. 998/HR 2213) Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act. Health cybersecurity legislation. Implementation of the Drug Supply Chain Security Act (DSCSA).
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213) Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act. Health cybersecurity legislation.
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Medical Supply Chain Resiliency Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.
FAST PASS Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act.
FAST PASS Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act. Monitoring of labor issues and work stoppages resulting from the International Longshoreman's Association strike affecting ports on the East Coast of the United States.
FAST PASS Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act.
BOLIVAR Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act.
BOLIVAR Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act. Monitoring of labor issues and work stoppages resulting from the International Longshoreman's Association strike affecting ports on the East Coast of the United States.
BOLIVAR Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act.
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
2026 · second_quarter · Q2
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Filing targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
2026 · first_quarter · Q1
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
S.257, the Promoting Resilient Supply Chains Act of 2025.
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Filing targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
2025 · fourth_quarter · Q4
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.
S.257, the Promoting Resilient Supply Chains Act of 2025.
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Federal Maritime Commission, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
2025 · third_quarter · Q3
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.
S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act.
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Federal Maritime Commission, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
2025 · second_quarter · Q2
Medical Supply Chain Resiliency Act (S. 998/HR 2213) Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act. Health cybersecurity legislation.
S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act.
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
2025 · first_quarter · Q1
Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025 Medical Supply Chain Resiliency Act (S. 998/HR 2213) Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act. Health cybersecurity legislation. Implementation of the Drug Supply Chain Security Act (DSCSA).
Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act. Monitoring of labor issues and work stoppages resulting from the International Longshoreman's Association strike affecting ports on the East Coast of the United States.
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Federal Maritime Commission, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Federal Maritime Commission, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office